1 July 2022 false Taxfiler 2023.12 true 9616590business:PrivateLimitedCompanyLtd2022-07-012023-06-30 96165902022-06-30 96165902022-07-012023-06-30 9616590business:AuditExemptWithAccountantsReport2022-07-012023-06-30 9616590business:FilletedAccounts2022-07-012023-06-30 96165902023-06-30 9616590business:Director12022-07-012023-06-30 9616590business:RegisteredOffice2022-07-012023-06-30 96165902022-06-30 9616590core:WithinOneYear2023-06-30 9616590core:WithinOneYear2022-06-30 9616590core:AfterOneYear2023-06-30 9616590core:AfterOneYear2022-06-30 9616590core:ShareCapitalcore:PreviouslyStatedAmount2023-06-30 9616590core:ShareCapitalcore:PreviouslyStatedAmount2022-06-30 9616590core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2023-06-30 9616590core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2022-06-30 9616590core:PreviouslyStatedAmount2023-06-30 9616590core:PreviouslyStatedAmount2022-06-30 9616590business:SmallEntities2022-07-012023-06-30 9616590countries:EnglandWales2022-07-012023-06-30 9616590core:LandBuildings2022-07-012023-06-30 9616590core:PlantMachinery2022-07-012023-06-30 9616590core:FurnitureFittings2022-07-012023-06-30 9616590core:ComputerEquipment2022-07-012023-06-30 9616590core:LandBuildings2022-06-30 9616590core:PlantMachinery2022-06-30 9616590core:FurnitureFittings2022-06-30 9616590core:ComputerEquipment2022-06-30 9616590core:LandBuildings2023-06-30 9616590core:PlantMachinery2023-06-30 9616590core:FurnitureFittings2023-06-30 9616590core:ComputerEquipment2023-06-30 9616590business:OrdinaryShareClass12022-07-012023-06-30 9616590business:OrdinaryShareClass12021-07-012022-06-30 96165902021-07-012022-06-30 iso4217:GBP xbrli:shares xbrli:pure
Company Registration No. 9616590 (England and Wales)
PROLASE CLINICS LTD Unaudited accounts for the year ended 30 June 2023
PROLASE CLINICS LTD Unaudited accounts Contents
Page
- 2 -
PROLASE CLINICS LTD Company Information for the year ended 30 June 2023
Director
MS K M MOORHOUSE
Company Number
9616590 (England and Wales)
Registered Office
28 BRIDGE STREET HITCHIN HERTS SG5 2DF
Accountants
NUMBER CRUNCHING LTD UNIT 5 FEN END STOTFOLD HERTS SG5 4BA
- 3 -
PROLASE CLINICS LTD Statement of financial position as at 30 June 2023
2023 
2022 
Notes
£ 
£ 
Fixed assets
Tangible assets
11,907 
18,387 
Current assets
Debtors
6,752 
8,340 
Cash at bank and in hand
5,891 
27,363 
12,643 
35,703 
Creditors: amounts falling due within one year
(123,263)
(134,419)
Net current liabilities
(110,620)
(98,716)
Total assets less current liabilities
(98,713)
(80,329)
Creditors: amounts falling due after more than one year
(10,000)
(15,000)
Provisions for liabilities
Deferred tax
(2,520)
(3,531)
Net liabilities
(111,233)
(98,860)
Capital and reserves
Called up share capital
100 
100 
Profit and loss account
(111,333)
(98,960)
Shareholders' funds
(111,233)
(98,860)
For the year ending 30 June 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 1 February 2024 and were signed on its behalf by
MS K M MOORHOUSE Director Company Registration No. 9616590
- 4 -
PROLASE CLINICS LTD Notes to the Accounts for the year ended 30 June 2023
1
Statutory information
PROLASE CLINICS LTD is a private company, limited by shares, registered in England and Wales, registration number 9616590. The registered office is 28 BRIDGE STREET, HITCHIN, HERTS, SG5 2DF.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Land & buildings
10% straight line
Plant & machinery
25% straight line
Fixtures & fittings
25% straight line
Computer equipment
over 3 years
Going concern
The director and shareholders have confirmed that they will continue to give financial support to the company until such time as its position improves. In addition, the director and shareholders have confirmed that they will not recall their loans within 12 months. The director considers that it is appropriate to prepare the financial statements on a going concern basis. The financial statements do not include any adjustments that would result if the financial support were withdrawn.
Deferred taxation
Deferred tax arises as a result of including items of income and expenditure in taxation computations in periods different from those in which they are included in the company's accounts. Deferred tax is provided in full on timing differences which result in an obligation to pay more (or less) tax at a future date, at the average tax rates that are expected to apply when the timing differences reverse, based on current tax rates and laws. Deferred tax assets and liabilities are not discounted.
- 5 -
PROLASE CLINICS LTD Notes to the Accounts for the year ended 30 June 2023
4
Tangible fixed assets
Land & buildings 
Plant & machinery 
Fixtures & fittings 
Computer equipment 
Total 
£ 
£ 
£ 
£ 
£ 
Cost or valuation
At cost 
At cost 
At cost 
At cost 
At 1 July 2022
6,295 
73,200 
3,356 
3,182 
86,033 
Additions
- 
4,543 
600 
- 
5,143 
At 30 June 2023
6,295 
77,743 
3,956 
3,182 
91,176 
Depreciation
At 1 July 2022
4,133 
57,878 
2,892 
2,743 
67,646 
Charge for the year
630 
10,109 
531 
353 
11,623 
At 30 June 2023
4,763 
67,987 
3,423 
3,096 
79,269 
Net book value
At 30 June 2023
1,532 
9,756 
533 
86 
11,907 
At 30 June 2022
2,162 
15,322 
464 
439 
18,387 
5
Debtors
2023 
2022 
£ 
£ 
Amounts falling due within one year
Trade debtors
299 
2,766 
Accrued income and prepayments
3,200 
321 
Other debtors
3,253 
5,253 
6,752 
8,340 
6
Creditors: amounts falling due within one year
2023 
2022 
£ 
£ 
Bank loans and overdrafts
5,000 
5,000 
Trade creditors
65 
3,247 
Taxes and social security
7,306 
5,796 
Other creditors
35,769 
39,066 
Loans from directors
74,523 
80,710 
Accruals
600 
600 
123,263 
134,419 
7
Creditors: amounts falling due after more than one year
2023 
2022 
£ 
£ 
Bank loans
10,000 
15,000 
8
Share capital
2023 
2022 
£ 
£ 
Allotted, called up and fully paid:
100 Ordinary shares of £1 each
100 
100 
- 6 -
PROLASE CLINICS LTD Notes to the Accounts for the year ended 30 June 2023
9
Average number of employees
During the year the average number of employees was 5 (2022: 5).
- 7 -